![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: VAPA |
Gene summary for VAPA |
![]() |
Gene information | Species | Human | Gene symbol | VAPA | Gene ID | 9218 |
Gene name | VAMP associated protein A | |
Gene Alias | VAMP-A | |
Cytomap | 18p11.22 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q9P0L0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9218 | VAPA | GSM4909285 | Human | Breast | IDC | 1.17e-03 | -1.03e-01 | 0.21 |
9218 | VAPA | GSM4909286 | Human | Breast | IDC | 5.23e-11 | -3.16e-01 | 0.1081 |
9218 | VAPA | GSM4909293 | Human | Breast | IDC | 2.76e-06 | -1.01e-01 | 0.1581 |
9218 | VAPA | GSM4909294 | Human | Breast | IDC | 2.65e-03 | -3.47e-01 | 0.2022 |
9218 | VAPA | GSM4909296 | Human | Breast | IDC | 4.32e-18 | -5.85e-01 | 0.1524 |
9218 | VAPA | GSM4909297 | Human | Breast | IDC | 4.20e-18 | -2.31e-01 | 0.1517 |
9218 | VAPA | GSM4909298 | Human | Breast | IDC | 2.58e-04 | -2.17e-01 | 0.1551 |
9218 | VAPA | GSM4909301 | Human | Breast | IDC | 2.56e-03 | -3.48e-01 | 0.1577 |
9218 | VAPA | GSM4909311 | Human | Breast | IDC | 1.84e-43 | -7.11e-01 | 0.1534 |
9218 | VAPA | GSM4909312 | Human | Breast | IDC | 3.79e-17 | -5.10e-01 | 0.1552 |
9218 | VAPA | GSM4909313 | Human | Breast | IDC | 3.54e-02 | -1.73e-01 | 0.0391 |
9218 | VAPA | GSM4909319 | Human | Breast | IDC | 5.22e-57 | -6.49e-01 | 0.1563 |
9218 | VAPA | GSM4909320 | Human | Breast | IDC | 1.70e-09 | -5.64e-01 | 0.1575 |
9218 | VAPA | GSM4909321 | Human | Breast | IDC | 4.62e-22 | -3.83e-01 | 0.1559 |
9218 | VAPA | brca1 | Human | Breast | Precancer | 4.59e-13 | 3.33e-01 | -0.0338 |
9218 | VAPA | brca2 | Human | Breast | Precancer | 1.17e-11 | 2.82e-01 | -0.024 |
9218 | VAPA | brca3 | Human | Breast | Precancer | 4.09e-12 | 3.45e-01 | -0.0263 |
9218 | VAPA | M1 | Human | Breast | IDC | 1.95e-05 | -4.29e-01 | 0.1577 |
9218 | VAPA | NCCBC14 | Human | Breast | DCIS | 2.88e-20 | -2.48e-01 | 0.2021 |
9218 | VAPA | NCCBC2 | Human | Breast | DCIS | 1.50e-05 | -2.53e-01 | 0.1554 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001603213 | Lung | AIS | viral process | 85/1849 | 415/18723 | 4.74e-11 | 1.95e-08 | 85 |
GO:001905813 | Lung | AIS | viral life cycle | 68/1849 | 317/18723 | 5.39e-10 | 1.16e-07 | 68 |
GO:005212613 | Lung | AIS | movement in host environment | 43/1849 | 175/18723 | 1.29e-08 | 1.88e-06 | 43 |
GO:005170113 | Lung | AIS | biological process involved in interaction with host | 47/1849 | 203/18723 | 2.09e-08 | 2.90e-06 | 47 |
GO:004440313 | Lung | AIS | biological process involved in symbiotic interaction | 58/1849 | 290/18723 | 1.33e-07 | 1.44e-05 | 58 |
GO:004852412 | Lung | AIS | positive regulation of viral process | 18/1849 | 65/18723 | 3.92e-05 | 1.19e-03 | 18 |
GO:005079213 | Lung | AIS | regulation of viral process | 32/1849 | 164/18723 | 1.33e-04 | 2.97e-03 | 32 |
GO:190390213 | Lung | AIS | positive regulation of viral life cycle | 10/1849 | 29/18723 | 2.96e-04 | 5.51e-03 | 10 |
GO:004312213 | Lung | AIS | regulation of I-kappaB kinase/NF-kappaB signaling | 41/1849 | 249/18723 | 7.57e-04 | 1.08e-02 | 41 |
GO:000724913 | Lung | AIS | I-kappaB kinase/NF-kappaB signaling | 45/1849 | 281/18723 | 7.90e-04 | 1.11e-02 | 45 |
GO:004819312 | Lung | AIS | Golgi vesicle transport | 46/1849 | 296/18723 | 1.32e-03 | 1.64e-02 | 46 |
GO:004390312 | Lung | AIS | regulation of biological process involved in symbiotic interaction | 16/1849 | 72/18723 | 1.50e-03 | 1.81e-02 | 16 |
GO:000690013 | Lung | AIS | vesicle budding from membrane | 14/1849 | 61/18723 | 2.09e-03 | 2.28e-02 | 14 |
GO:001907913 | Lung | AIS | viral genome replication | 24/1849 | 131/18723 | 2.14e-03 | 2.30e-02 | 24 |
GO:190390013 | Lung | AIS | regulation of viral life cycle | 26/1849 | 148/18723 | 2.64e-03 | 2.68e-02 | 26 |
GO:000724922 | Lung | AAH | I-kappaB kinase/NF-kappaB signaling | 21/613 | 281/18723 | 4.01e-04 | 1.78e-02 | 21 |
GO:004312222 | Lung | AAH | regulation of I-kappaB kinase/NF-kappaB signaling | 19/613 | 249/18723 | 5.79e-04 | 2.23e-02 | 19 |
GO:001905823 | Lung | AAH | viral life cycle | 21/613 | 317/18723 | 1.85e-03 | 4.31e-02 | 21 |
GO:001905833 | Lung | MIAC | viral life cycle | 36/967 | 317/18723 | 8.00e-06 | 7.07e-04 | 36 |
GO:005212623 | Lung | MIAC | movement in host environment | 23/967 | 175/18723 | 3.58e-05 | 1.97e-03 | 23 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa049792 | Liver | Cirrhotic | Cholesterol metabolism | 30/2530 | 51/8465 | 1.59e-05 | 1.39e-04 | 8.60e-05 | 30 |
hsa049793 | Liver | Cirrhotic | Cholesterol metabolism | 30/2530 | 51/8465 | 1.59e-05 | 1.39e-04 | 8.60e-05 | 30 |
hsa049794 | Liver | HCC | Cholesterol metabolism | 41/4020 | 51/8465 | 1.33e-06 | 1.35e-05 | 7.49e-06 | 41 |
hsa049795 | Liver | HCC | Cholesterol metabolism | 41/4020 | 51/8465 | 1.33e-06 | 1.35e-05 | 7.49e-06 | 41 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
VAPA | SNV | Missense_Mutation | rs376344309 | c.782N>T | p.Ser261Leu | p.S261L | Q9P0L0 | protein_coding | tolerated(0.22) | benign(0.306) | TCGA-C8-A26Y-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
VAPA | SNV | Missense_Mutation | c.757C>G | p.His253Asp | p.H253D | Q9P0L0 | protein_coding | tolerated(0.41) | possibly_damaging(0.6) | TCGA-GM-A2DB-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxol | CR | |
VAPA | SNV | Missense_Mutation | rs773854854 | c.743T>C | p.Leu248Pro | p.L248P | Q9P0L0 | protein_coding | deleterious(0.02) | probably_damaging(0.988) | TCGA-A6-A565-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unspecific | 5FU | PD |
VAPA | SNV | Missense_Mutation | c.128N>T | p.Ser43Leu | p.S43L | Q9P0L0 | protein_coding | deleterious(0.04) | probably_damaging(0.968) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
VAPA | SNV | Missense_Mutation | novel | c.194N>A | p.Ser65Asn | p.S65N | Q9P0L0 | protein_coding | deleterious(0) | probably_damaging(0.979) | TCGA-AA-3950-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
VAPA | deletion | Frame_Shift_Del | c.348delN | p.Lys117AsnfsTer5 | p.K117Nfs*5 | Q9P0L0 | protein_coding | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
VAPA | SNV | Missense_Mutation | c.763N>A | p.Asp255Asn | p.D255N | Q9P0L0 | protein_coding | tolerated(0.29) | possibly_damaging(0.526) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
VAPA | SNV | Missense_Mutation | novel | c.248T>C | p.Phe83Ser | p.F83S | Q9P0L0 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AJ-A2QO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
VAPA | SNV | Missense_Mutation | novel | c.461G>A | p.Ser154Asn | p.S154N | Q9P0L0 | protein_coding | tolerated(0.44) | benign(0.003) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
VAPA | SNV | Missense_Mutation | rs773084616 | c.560N>C | p.Met187Thr | p.M187T | Q9P0L0 | protein_coding | deleterious(0.04) | benign(0.046) | TCGA-B5-A0JT-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Hormone Therapy | megace | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |